Effective combined immunotherapy for severe hemolytic disease of the fetus

Annina Capraru, Michael Daskalakis, Martin Mueller, Luigi Raio, Behrouz Mansouri Taleghani, Sacha Zeerleder

Open source

DOI
10.1111/trf.70426
Published
2026-10-20
Container
Transfusion
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/trf.70426,
  title = {Effective combined immunotherapy for severe hemolytic disease of the fetus},
  author = {Annina Capraru and Michael Daskalakis and Martin Mueller and Luigi Raio and Behrouz Mansouri Taleghani and Sacha Zeerleder},
  year = {2026},
  journal = {Transfusion},
  doi = {10.1111/trf.70426},
  url = {https://doi.org/10.1111/trf.70426}
}

RIS

TY  - JOUR
TI  - Effective combined immunotherapy for severe hemolytic disease of the fetus
AU  - Annina Capraru
AU  - Michael Daskalakis
AU  - Martin Mueller
AU  - Luigi Raio
AU  - Behrouz Mansouri Taleghani
AU  - Sacha Zeerleder
PY  - 2026
JO  - Transfusion
DO  - 10.1111/trf.70426
UR  - https://doi.org/10.1111/trf.70426
ER  - 

APA

Capraru, A., Daskalakis, M., Mueller, M., Raio, L., Taleghani, B. M., & Zeerleder, S. (2026). Effective combined immunotherapy for severe hemolytic disease of the fetus. Transfusion. https://doi.org/10.1111/trf.70426

Source records